Physician

Aaron James Pomajzl, M.D.

According to 2025 Medicare claims, Aaron Pomajzl, M.D. (NPI: 1932550084) practices urology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is NEBRASKA UROLOGY PC (NPI: 1356364335; TIN: 470540928) and primary practice location at 68516-3389. Pomajzl is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287) and Bryan Health Connect ACO, LLC (ACO ID: A4573), participating under the MSSP model.

Pomajzl's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 520 traditional Medicare patients, billed 4,695 HCPCS/CPT codes, and received $179,340 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,430 prescription claims across 355 beneficiaries totaling $559,988 in drug costs, led by Xtandi (Enzalutamide). DME data shows 40 claims. Open Payments data shows 28 records totaling $576. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,124 to $559,988. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	231	1,708	$56,099
2022	580	6,255	$177,657
2023	583	4,828	$184,811
2024	520	4,695	$179,340

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	53	80	$2,124
2018	69	106	$1,844
2019	29	63	$433
2020	24	54	$5,209
2021	148	322	$16,583
2022	315	1,328	$170,607
2023	304	1,452	$242,199
2024	355	1,430	$559,988

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	76	$14,922
2023	N/R	75	$23,962
2024	N/R	40	$21,327

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	253	308	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	130	147	$52
36415	Insertion of needle into vein for collection of blood sample	108	132	$9
51798	Ultrasound measurement of bladder capacity after voiding	158	219	$7
81001	Manual urinalysis test with examination using microscope, automated	177	239	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	26	780	$341,671
Erleada	Apalutamide	11	330	$144,449
Myrbetriq	Mirabegron	64	2,545	$36,569
Tamsulosin Hcl	Tamsulosin Hcl	554	32,849	$9,384
Gemtesa	Vibegron	15	510	$8,456

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	26	$21,158
A4332	Lubricant, individual sterile packet, each	N	N/R	14	$169

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$576	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron James Pomajzl, M.D.?

Tedicare shows public-source Medicare data for Aaron James Pomajzl, M.D. (NPI 1932550084), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron James Pomajzl, M.D. have ACO affiliation data?

Aaron James Pomajzl, M.D. is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287) and Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573).

What billing organization is linked to Aaron James Pomajzl, M.D.?

Aaron James Pomajzl, M.D. is linked to NEBRASKA UROLOGY PC (billing NPI 1356364335) in the available physician profile data.

Does Aaron James Pomajzl, M.D. have Open Payments data?

Aaron James Pomajzl, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.